Company Société des Industries Pharmaceutiques de Tunisie - S.A.

SIPHA

TN0006670012

Pharmaceuticals

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

SOCIÉTÉ DES INDUSTRIES PHARMACEUTIQUES DE TUNISIE - S.A.

End-of-day quote Tunis Other stock markets 03:30:00 09/05/2024 am IST			5-day change	1st Jan Change
3.92 ^TND	-2.00%		0.00%	+4.26%

2021

Société des Industries Pharmaceutiques de Tunisie - S.A. Reports Earnings Results for the Full Year Ended December 31, 2019

Société des Industries Pharmaceutiques de Tunisie (SIPHAT) specializes in manufacturing and marketing pharmaceutical products. Net sales break down by source of income as follows:

- sales to hospitals (52.1%);

- sales to consumer (43.8%);

The remaining net sales (4.1%) are from the overseas sale activity.

TND in Million	2018	Weight	2019	Weight	Delta
Pharmaceutical Products 100.0 %	33	100.0 %	24	100.0 %	-26.22%

TND in Million	2018	Weight	2019	Weight	Delta
Tunisia 100.0 %	33	100.0 %	24	100.0 %	-26.22%

Managers	Title	Age	Since
Anis Klouz CEO	Chief Executive Officer	-	19/17/19
Emin Cherni AUD	Comptroller/Controller/Auditor	-	-

Members of the board	Title	Age	Since
Anis Klouz CEO	Chief Executive Officer	-	19/17/19
Wasila Hamami BRD	Director/Board Member	-	01/19/01
Ridha Saidi BRD	Director/Board Member	-	01/19/01
Ali Mekki BRD	Director/Board Member	-	01/19/01
Tarek Bouhlel BRD	Director/Board Member	-	01/19/01
Nabil Hani BRD	Director/Board Member	-	01/19/01
Imed Ben Khater BRD	Director/Board Member	-	01/19/01
Mourad Doghri BRD	Director/Board Member	-	01/19/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,800,000	360,145 ( 20.01 %)	0	20.01 %

Société des Industries Pharmaceutiques de Tunisie SA

Fondouk Choucha

2013, Ben Arous

http://www.siphat.rns.tn

address Société des Industries Pharmaceutiques de Tunisie - S.A.(SIPHA)

Sell

Buy

Mean consensus

SELL

Number of Analysts

Last Close Price

3.92 TND

Average target price

0.29 TND

Spread / Average Target

-92.60%

Consensus

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
SOCIÉTÉ DES INDUSTRIES PHARMACEUTIQUES DE TUNISIE - S.A.	+4.26%	2.27M
ELI LILLY AND COMPANY	+32.09%	693B
NOVO NORDISK A/S	+29.39%	584B
JOHNSON & JOHNSON	-1.34%	372B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+7.39%	294B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	211B
NOVARTIS AG	+10.02%	210B
AMGEN INC.	+8.49%	168B

Other Pharmaceuticals